Three Generations of Ongoing Controversies Concerning the Use of Short Acting Beta-Agonist Therapy in Asthma: A Review

By Jalba Mihai-Sergiu  

Journal of Asthma, Vol. 45, Iss. 1, 2008-01 ,pp. : 9-18

Informa Healthcare

Access to resources Recommend Favorite

Quarterly Assessment of Short-Acting β₂-Adrenergic Agonist Use as a Predictor of Subsequent Health Care Use for Asthmatic Patients in the United States

By Silver Harris S.   Blanchette Christopher M   Kamble Shital   Petersen Hans   Letter Matthew   Meddis David   Gutierrez Benjamin  

Journal of Asthma, Vol. 47, Iss. 6, 2010-08 ,pp. : 660-666

Informa Healthcare

Access to resources Recommend Favorite

Efficacy and Safety of Inhaled Corticosteroids in Combination with a Long-Acting Beta 2 -Agonist in Asthmatic Children Under Age 5

By Sekhsaria Sudhir   Alam Mikhayl   Sait Tahir   Starr Barnaby   Parekh Monica  

Journal of Asthma, Vol. 41, Iss. 5, 2004-01 ,pp. : 575-582

Informa Healthcare

Access to resources Recommend Favorite

The use of long- and short-acting forms of gonadotrophin-releasing hormone analogues in women undergoing oocyte donation

By Neuspiller F   Levy M   Remohi J   Ruiz A   Simon C   Pellicer A  

Human Reproduction, Vol. 13, Iss. 5, 1998-05 ,pp. : 1148-1151

Oxford University Press

Access to resources Recommend Favorite

Airway Responsiveness to Beta-Adrenergic Agonist (Salbutamol) in Asthma

By Boskabady Mohammad Hossein   Saadatinejad Mariam  

Journal of Asthma, Vol. 40, Iss. 8, 2003-12 ,pp. : 917-925

Informa Healthcare

Access to resources Recommend Favorite